Media

All the posts published.

NetScientific gaining critical mass with commercial ramp-up of portfolio

Dec 14, 2017
-
Media, News
Francois Martelet, chief executive of NetScientific PLC (LON:NSCI) caught up with Proactive’s Andrew Scott to update on developments within the IP commercialisation specialist’s portfolio. https://youtu.be/_5_-vQTbvp0 Francois Martelet, chief executive of NetScientific PLC (LON:NSCI), caught up with Proactive's Andrew Scott to update on developments within the IP commercialisation specialist's portfolio. ''All of our companies are game-changing [...]

NetScientific H1 2018 Planned Investor Event and Conference Attendance

Jan 6, 2018
-
Media, News
London, UK – 05 January 2018 – NetScientific plc (AIM:NSCI), the transatlantic healthcare IP commercialisation group, today announces that its management team will attend the following key investor and partnering conferences in the first half of 2018: IDATE DigiWorld – London Members Yearly Meeting January 18th 2018 London, UK Francois Martelet, CEO, to attend   [...]

NetScientific CEO to Present at Shares Investor Evening at 19:30 on the 14th December 2017

Dec 8, 2017
-
Media, News
  London, UK – 08 December 2017 – NetScientific plc (“NetScientific”, AIM:NSCI), the transatlantic healthcare IP commercialisation group announces that Francois Martelet, Chief Executive Officer, will be presenting at the Shares Investor Evening in London at the Novotel Tower Bridge, London EC3N 2NR on Thursday 14 December at 19:30 GMT # # # For more [...]

EXECUTIVE INTERVIEW – NETSCIENTIFIC

Oct 11, 2017
-
Media, News
 

NetScientific chief François Martelet on the ‘strong return’ from sale of OncoVerse

Apr 25, 2017
-
Media, News

Netscientific Overview 2017 Video

Apr 25, 2017
-
Media, News
François Martelet M.D Netscientific Chief Executive Officer speaks about Netscientific transatlantic healthcare technology group. NetScientific is a transatlantic healthcare IP commercialisation group. We fund and develop companies that significantly improve the health and well-being of people with chronic diseases. Through our US-UK network, we source, develop and manage early/mid-stage healthcare technology companies focused on Diagnostics, [...]

SLAS 2017 Innovation Award for VortexBioSciences Liquid Biopsy Video

Mar 16, 2017
-
Media, News

NetScientific – François Martelet M.D. Chief Executive Officer proud of cancer diagnostic tool’s achievements

Feb 23, 2017
-
Media, News

NetScientific plc chief hails progress at Vortex Biosciences

Nov 7, 2016
-
Media, News
NetScientific plc (LON:NSCI) chief executive and chairman Francois Martelet hailed recent news from portfolio company Vortex Biosciences as a "very important" milestone. Vortex has been awarded a CE Mark for its circulating tumour cell (CTC) capture system and has registered a Class I medical device with the US FDA (Food and Drug Administration). It means [...]

NetScientific PLC focused on “execution, execution and execution”

Sep 27, 2016
-
Glycotest, Media, News, ProAxsis
Biomedical and healthcare incubator NetScientific PLC (LON:NSCI) had a busy first half to the year, focusing on “execution, execution, execution”, according to chief executive officer François Martelet. Backed by its world class scientific advisory boards, the investment company’s emphasis has been on accelerating its core portfolio companies - Wanda, Vortex Biosciences, Glycotest and ProAxsis - [...]
Media Archives - NetScientific